We demonstrated that MAPK8IP1 overexpression and SH3GLB1 knockdown inhibited the proliferation, migration and invasion of glioma cells and increased sensitivity to Temozolomide. This evidence concerns the gene SH3GLB1 and central nervous system cancer.